Physician profile
Joseph Stokes
NPI 1336667955
$15,892.37
in general payments reported to CMS, 2019-2025
35 companies · $3,610 in 2025
The $3,610 reported for 2025 was more than what 98% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $949 · 2022: $2,909 · 2023: $3,695 · 2024: $4,730 · 2025: $3,610.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Education: $49.96.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,985.02 |
| Education | $49.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $5,220.15 | 2021-2025 | Dovato, Apretude, Rukobia |
| Gilead Sciences, INC. | $2,209.45 | 2021-2025 | |
| Abbvie INC. | $1,615.62 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $1,002.52 | 2021-2025 | Pifeltro, Delstrigo, Dificid |
| Novo Nordisk INC | $957.41 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Napo Pharmaceuticals INC | $735.67 | 2021-2025 | Mytesi |
| Axsome Therapeutics, INC. | $512.32 | 2023-2025 | Auvelity |
| Amgen INC. | $492.55 | 2022-2025 | Repatha, Otezla, Repatha |
| Emd Serono, INC. | $458.33 | 2021-2025 | Serostim |
| Theratechnologies INC. | $432.25 | 2021-2025 | Trogarzo, Egrifta |
| Janssen Pharmaceuticals, INC | $354.15 | 2022-2025 | Spravato, Symtuza |
| Lilly USA, LLC | $350.64 | 2023-2025 | Mounjaro, Zepbound, Trulicity |
| Otsuka America Pharmaceutical, INC. | $191.21 | 2022-2025 | Rexulti, Abilify Maintena |
| Novartis Pharmaceuticals Corporation | $177.96 | 2022-2025 | |
| Janssen Biotech, INC. | $135.94 | 2021-2023 | Symtuza |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $135.20 | 2021-2025 | Trintellix |
| Exact Sciences Corporation | $90.69 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Astrazeneca Pharmaceuticals Lp | $90.65 | 2025 | Breztri, Farxiga |
| Pfizer INC. | $79.92 | 2023-2025 | |
| Antares Pharma, INC. | $75.38 | 2022-2023 | Tlando, Xyosted, Nocdurna |
| Lundbeck LLC | $70.49 | 2022-2025 | Rexulti |
| Idorsia Pharmaceuticals US INC | $67.43 | 2022-2023 | Quviviq |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $64.09 | 2021-2025 | Xifaxan, Trulance |
| Abbott Laboratories | $59.13 | 2024-2025 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $57.34 | 2023 | Trelegy Ellipta, Arexvy, Shingrix |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $42.37 | 2023-2025 | Caplyta |
| Halozyme INC | $32.01 | 2023 | |
| Janssen Products, Lp | $31.49 | 2022 | |
| Ardelyx, INC. | $30.71 | 2024 | Ibsrela |
| Inspire Medical Systems, INC. | $25.00 | 2024 | Inspire |
| Biohaven Pharmaceutical Holding Company Ltd. | $21.38 | 2022 | |
| Corium, LLC | $21.38 | 2023 | Azstarys |
| Corcept Therapeutics | $19.48 | 2024 | Korlym |
| Currax Pharmaceuticals LLC | $16.21 | 2025 | Contrave |
| Azurity Pharmaceuticals, INC. | $15.85 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Stokes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.